8-K
filed February 11, 2025, 6:59 PM ET
ticker CYTK
CIK 0001061983
leadership
confidence high
sentiment neutral
materiality 0.25
Cytokinetics appoints Robert E. Landry to Board of Directors, effective Feb 10, 2025
CYTOKINETICS INC
- Robert E. Landry appointed as Class II director, term expiring at 2027 annual meeting.
- Also appointed to Audit Committee; Board determined independent under SEC and Nasdaq rules.
- Compensation includes $50k annual retainer, $12.5k Audit Committee retainer, and annual equity grant of $440k.
- Received initial option grant of 25,538 shares with $700k grant date fair value, vesting over three years.
- Standard indemnification agreement entered into; no other arrangements or transactions requiring disclosure.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0000950170-25-017458
- form_type
- 8-K
- ticker
- CYTK
- cik
- 0001061983
- company_name
- CYTOKINETICS INC
- filed_at
- 2025-02-11T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:02.840627+00:00
- generated_at
- 2026-05-26T23:12:54.107890+00:00
- sec_items
- ["5.02"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.25
- calibrated_materiality_score
- 0.25
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0000950170-25-017458
- json_url
- https://secwatch.observer/filing/0000950170-25-017458.json
- markdown_url
- https://secwatch.observer/filing/0000950170-25-017458.md
- text_url
- https://secwatch.observer/filing/0000950170-25-017458.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1061983/000095017025017458/0000950170-25-017458-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1061983/000095017025017458/cytk-20250210.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
MZYX
MOZAYYX Acquisition appoints Emma Rose Bienvenu as independent director
MOZAYYX Acquisition Corp.
June 1, 2026, 5:00 PM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On February 10, 2025, (the “ Effective Date ”), the Board of Directors (the “ Board ”) of Cytokinetics, Incorporated (the “ Company ”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert E. Landry to fill a vacant Board seat and to serve as a Class II member of the Board with an initial term expiring at the Company’s 2027 annual meeting of stockholders.
Comparable filing
On May 26, 2026, the Board of Directors (the “ Board ”) of MOZAYYX Acquisition Corp. (the “ Company ”) appointed Emma Rose Bienvenu to serve as an independent director of the Company, effective immediately.
Filing page
SEC filing
JOB
Darla Moore resigns from GEE Group board effective June 1, 2026, due to other commitments
GEE Group Inc.
June 1, 2026, 4:47 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On February 10, 2025, (the “ Effective Date ”), the Board of Directors (the “ Board ”) of Cytokinetics, Incorporated (the “ Company ”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert E. Landry to fill a vacant Board seat and to serve as a Class II member of the Board with an initial term expiring at the Company’s 2027 annual meeting of stockholders.
Comparable filing
On June 1, 2026, GEE Group Inc. (the “Company”) (NYSE American: JOB) issued a press release announcing that Ms. Darla Moore, has resigned as a member of the Board of Directors (the “Board”) and from all committees of the Company’s Board effective June 1, 2026, due to the time requirements necessary for her existing and new business commitments.
Filing page
SEC filing
SERA
Sera Prognostics director Jeff Elliott resigns ahead of annual meeting
SERA PROGNOSTICS, INC.
June 1, 2026, 4:44 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On February 10, 2025, (the “ Effective Date ”), the Board of Directors (the “ Board ”) of Cytokinetics, Incorporated (the “ Company ”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert E. Landry to fill a vacant Board seat and to serve as a Class II member of the Board with an initial term expiring at the Company’s 2027 annual meeting of stockholders.
Comparable filing
Jeffrey T. Elliott, a member of the Board of Directors (the “Board”) of Sera Prognostics, Inc. (the “Company”), notified the Company of his decision to resign from the Board effective as of June 4, 2026
Filing page
SEC filing
FTI
TechnipFMC appoints Eric D. Mullins to Board of Directors effective June 1, 2026
TechnipFMC plc
June 1, 2026, 4:38 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On February 10, 2025, (the “ Effective Date ”), the Board of Directors (the “ Board ”) of Cytokinetics, Incorporated (the “ Company ”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert E. Landry to fill a vacant Board seat and to serve as a Class II member of the Board with an initial term expiring at the Company’s 2027 annual meeting of stockholders.
Comparable filing
the Board elected Eric Mullins to the Board and appointed Mr. Mullins to the Audit Committee of the Board, effective June 1, 2026.
Filing page
SEC filing
MCRB
Seres Therapeutics board member Hans-Juergen Woerle resigns, effective May 31, 2026
Seres Therapeutics, Inc.
June 1, 2026, 4:30 PM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On February 10, 2025, (the “ Effective Date ”), the Board of Directors (the “ Board ”) of Cytokinetics, Incorporated (the “ Company ”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert E. Landry to fill a vacant Board seat and to serve as a Class II member of the Board with an initial term expiring at the Company’s 2027 annual meeting of stockholders.
Comparable filing
On May 30, 2026, Hans-Juergen Woerle, M.D., Ph.D. resigned from his position as a member of the board of directors of Seres Therapeutics, Inc. (the “Company”) and on the committees on which he serves, effective May 31, 2026.
Filing page
SEC filing
MCHP
Microchip appoints former SVP Mitch Little to board, effective June 1, 2026
MICROCHIP TECHNOLOGY INC
June 1, 2026, 4:18 PM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On February 10, 2025, (the “ Effective Date ”), the Board of Directors (the “ Board ”) of Cytokinetics, Incorporated (the “ Company ”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert E. Landry to fill a vacant Board seat and to serve as a Class II member of the Board with an initial term expiring at the Company’s 2027 annual meeting of stockholders.
Comparable filing
appointed Mitch Little, former Senior Vice President, Worldwide Client Engagement of Microchip, as a member of the Board, effective June 1, 2026.
Filing page
SEC filing
PUMP
Director Alex Volkov resigns from ProPetro board after Pioneer (Exxon) sells all shares
ProPetro Holding Corp.
June 1, 2026, 4:16 PM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On February 10, 2025, (the “ Effective Date ”), the Board of Directors (the “ Board ”) of Cytokinetics, Incorporated (the “ Company ”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert E. Landry to fill a vacant Board seat and to serve as a Class II member of the Board with an initial term expiring at the Company’s 2027 annual meeting of stockholders.
Comparable filing
On May 28, 2026, ProPetro Holding Corp. (the “Company”) announced the resignation of Alex V. Volkov from the Company’s Board of Directors (the “Board”).
Filing page
SEC filing
DE
Deere director Dmitri Stockton will not seek re-election at 2027 annual meeting
DEERE & CO
June 1, 2026, 4:15 PM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On February 10, 2025, (the “ Effective Date ”), the Board of Directors (the “ Board ”) of Cytokinetics, Incorporated (the “ Company ”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert E. Landry to fill a vacant Board seat and to serve as a Class II member of the Board with an initial term expiring at the Company’s 2027 annual meeting of stockholders.
Comparable filing
On May 26, 2026, Dmitri Stockton notified the Board of Directors (the “Board”) of Deere & Company (the “Company”) that he would not stand for re-election as a director at the 2027 annual meeting of stockholders.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.